Two‐year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double‐blind, placebo‐controlled …
…, JA Block, J Wing, HH McIlwain… - … : Official Journal of …, 2001 - Wiley Online Library
Objective To evaluate the continued efficacy and safety of alendronate (ALN) for up to 2
years in patients receiving glucocorticoids. Methods This is a 12‐month extension of a …
years in patients receiving glucocorticoids. Methods This is a 12‐month extension of a …
Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study
…, TW Littlejohn, SL Schwartz, SR Weiss, HH McIlwain… - Jama, 2003 - jamanetwork.com
ContextObese individuals tend to resist the weight-regulating effects of exogenously administered
leptin. A genetically engineered recombinant human variant ciliary neurotrophic factor …
leptin. A genetically engineered recombinant human variant ciliary neurotrophic factor …
A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis.
…, A Melian, DR Mandel, HH McIlwain… - The Journal of …, 2002 - jrheum.org
OBJECTIVE: To evaluate the efficacy and tolerability of the highly selective cyclooxygenase-2
(COX-2) inhibitor etoricoxib for the treatment of rheumatoid arthritis (RA). METHODS: A …
(COX-2) inhibitor etoricoxib for the treatment of rheumatoid arthritis (RA). METHODS: A …
Glucocorticoid-induced osteoporosis: pathogenesis, diagnosis, and management
HH McIlwain - Preventive Medicine, 2003 - Elsevier
Glucocorticoid-induced bone loss is dose- and duration-related, develops rapidly (within
months of therapy), and leads to an increased risk of fractures. Moreover, less than one in four …
months of therapy), and leads to an increased risk of fractures. Moreover, less than one in four …
Use of fluoxetine, a selective serotonin-uptake inhibitor, in the treatment of obesity: a dose-response study (with a commentary by Michael Weintraub).
…, B Levy, CP Lucas, HH McIlwain - … Journal of Obesity, 1989 - europepmc.org
Pharmacologic measures which increase serotonergic activity in the brain decrease food
consumption and lead to decreased weight in animals. Fluoxetine, an inhibitor of serotonin …
consumption and lead to decreased weight in animals. Fluoxetine, an inhibitor of serotonin …
Effects of prasterone on bone mineral density in women with active systemic lupus erythematosus receiving chronic glucocorticoid therapy
…, EM Ginzler, YRS Sherrer, HH McIlwain… - The Journal of …, 2008 - jrheum.org
Objective To assess prevention of bone mineral density (BMD) loss and durability of the
response during treatment with prasterone in women with systemic lupus erythematosus (SLE) …
response during treatment with prasterone in women with systemic lupus erythematosus (SLE) …
Piroxicam versus naproxen in the treatment of acute musculoskeletal disorders in athletes
HH McIlwain, RD Platt - The American Journal of Medicine, 1988 - Elsevier
Safe and effective therapy for acute musculoskeletal disorders would be extremely useful for
competitive athletes. These injuries are common in these patients, who are usually highly …
competitive athletes. These injuries are common in these patients, who are usually highly …
Metabolic response in vitro to electrical stimulation of sections of mammalian brain
H McIlwain - Biochemical Journal, 1951 - ncbi.nlm.nih.gov
… This subject has recently beenreviewed by McIlwain (1950a). … in vitro (McIlwain, Buchel &
Cheshire, 1951; McIlwain, 1950b) and can maintain cozymase (Gore, Ibbott& McIlwain, 1950) …
Cheshire, 1951; McIlwain, 1950b) and can maintain cozymase (Gore, Ibbott& McIlwain, 1950) …
[BOOK][B] Diet for a Pain-Free Life
HH McIlwain, DF Bruce - 2012 - books.google.com
… McIlwain asked me totrythe PainFree Diet at a routine visit last year. Admittedly, I’ma
meateaterandthe ideaof eliminatingall beef, pork,andveal from my diet wasnot attractive. ButI was …
meateaterandthe ideaof eliminatingall beef, pork,andveal from my diet wasnot attractive. ButI was …
Flare during drug withdrawal as a method to support efficacy in rheumatoid arthritis: amiprilose hydrochloride as an example in a double blind, randomized study.
…, RA Bonebrake, WB Gruhn, HH McIlwain… - The Journal of …, 1998 - europepmc.org
Objective To evaluate the use of a randomized, double blind, drug withdrawal design as a
means to test the efficacy of longterm therapy with antirheumatic drugs. Methods We …
means to test the efficacy of longterm therapy with antirheumatic drugs. Methods We …